welcome
Investor's Business Daily

Investor's Business Daily

Health

Health

Vigil Neuroscience stock soars after drugmaker Sanofi agrees to buy it for $470 million

Investor's Business Daily
Summary
Nutrition label

68% Informative

Vigil Neuroscience (VIGL) tripled Thursday after Sanofi agreed to buy it for $470 million plus a contingent value right tied to its experimental Alzheimer's treatment.

Vigil stock catapulted more than 242% to 7.91 , within striking distance of the takeover price at $ 8 a share.

The companies expect the deal to close in the third quarter .

VR Score

65

Informative language

66

Neutral language

13

Article tone

formal

Language

English

Language complexity

40

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links